Ipersart

Losartan potassium and hydrochlorothiazide, the active ingredients in Ipersart, are an angiotensin II receptor blocker and thiazide diuretic combination presented as an oral tablet for adult use. It treats hypertension by lowering blood pressure in patients who need dual‑action therapy.

GNH USA supplies Ipersart as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipersart, a combined antihypertensive, is indicated for conditions related to elevated blood pressure.

- Essential hypertension: reduces systolic and diastolic blood pressure to target levels. - Resistant hypertension: provides additional blood‑pressure control when monotherapy is insufficient. - Hypertensive patients with fluid retention: adds diuretic action to improve overall pressure management.

Common and serious adverse reactions have been reported with the losartan/hydrochlorothiazide combination.

Common Side Effects: - Dizziness: light‑headed sensation, especially after standing. - Headache: mild to moderate intensity. - Fatigue: general feeling of tiredness. - Increased urination: due to diuretic effect. - Electrolyte imbalance: mild changes in potassium or sodium levels. - Cough: occasional dry throat irritation.

Serious or Rare Side Effects: - Severe hypotension: dangerously low blood pressure. - Acute kidney injury: sudden decline in renal function. - Hyperkalemia: elevated potassium that may cause cardiac issues. - Allergic reaction: rash, itching, or swelling. - Liver dysfunction: abnormal liver enzyme elevations. - Pancreatitis: inflammation of the pancreas.

Before prescribing Ipersart, clinicians should consider several safety and handling precautions. - Renal impairment: assess kidney function and adjust dose if necessary. - Electrolyte monitoring: check serum potassium and sodium regularly. - Pregnancy: contraindicated in pregnancy (Category D) due to fetal risk. - Concomitant potassium‑sparing agents: avoid to prevent hyperkalemia. - Severe liver disease: use with caution as metabolism may be affected. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture.

Ipersart may interact with other medicines, requiring attention to avoid adverse effects.

Major Interactions (Avoid): - ACE inhibitors or aliskiren: risk of additive renal dysfunction and hyperkalemia. - Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia. - NSAIDs: can reduce antihypertensive efficacy and impair kidney function.

Moderate Interactions (Monitor Closely): - Lithium: increased lithium levels, monitor for toxicity. - Antidiabetic drugs: diuretic may enhance hypoglycemic effect, adjust dose as needed. - Other antihypertensives: may cause excessive blood pressure lowering, monitor BP.